title: Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis.
abstract: Accumulating evidence suggests that oxidation-specific epitopes (OSEs) constitute a novel class of damage-associated molecular patterns (DAMPs) generated during high oxidative stress but also in the physiological process of apoptosis. To deal with the potentially harmful consequences of such epitopes, the immune system has developed several mechanisms to protect from OSEs and to orchestrate their clearance, including IgM natural antibodies and both cellular- and membrane-bound receptors. Here, we focus on malondialdehyde (MDA) epitopes as prominent examples of OSEs that trigger both innate and adaptive immune responses. First, we review the mechanisms of MDA generation, the different types of adducts on various biomolecules and provide relevant examples for physiological carriers of MDA such as apoptotic cells, microvesicles, or oxidized low-density lipoproteins. Based on recent insights, we argue that MDA epitopes contribute to the maintenance of homeostatic functions by acting as markers of elevated oxidative stress and tissue damage. We discuss multiple lines of evidence that MDA epitopes are proinflammatory and thus important targets of innate and adaptive immune responses. Finally, we illustrate the relevance of MDA epitopes in human pathologies by describing their capacity to drive inflammatory processes in atherosclerosis and highlighting protective mechanisms of immunity that could be exploited for therapeutic purposes.
authors.affiliation: Medical University of Vienna, Vienna, Austria; Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria.
authors.forename: N
authors.initials: N
authors.lastname: Papac-Milicevic
authors.affiliation: Medical University of Vienna, Vienna, Austria; Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria.
authors.forename: C J-L
authors.initials: CJ
authors.lastname: Busch
authors.affiliation: Medical University of Vienna, Vienna, Austria; Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria. Electronic address: christoph.binder@meduniwien.ac.at.
authors.forename: C J
authors.initials: CJ
authors.lastname: Binder
mesh_terms: D056704:Adaptive Immunity; D000818:Animals; D001161:Arteriosclerosis / Q000276:immunology*; D018985:Epitopes, B-Lymphocyte / Q000378:metabolism*; D006706:Homeostasis; D006801:Humans; D007113:Immunity, Innate; D007075:Immunoglobulin M / Q000378:metabolism; D007249:Inflammation / Q000276:immunology*; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008315:Malondialdehyde / Q000378:metabolism*; D010084:Oxidation-Reduction; D018384:Oxidative Stress
chemical_list: D018985:Epitopes, B-Lymphocyte; D007075:Immunoglobulin M; D008077:Lipoproteins, LDL; D008315:Malondialdehyde
keywords: Atherosclerosis; Damage-associated molecular pattern; Immunity; Inflammation; Malondialdehyde; Oxidation-specific epitopes; Oxidative stress; Oxidized low-density lipoprotein